2022
DOI: 10.1080/19420862.2022.2083465
|View full text |Cite
|
Sign up to set email alerts
|

Engineering death resistance in CHO cells for improved perfusion culture

Abstract: The reliable and cost-efficient manufacturing of monoclonal antibodies (mAbs) is essential to fulfil their ever-growing demand. Cell death in bioreactors reduces productivity and product quality, and is largely attributed to apoptosis. In perfusion bioreactors, this leads to the necessity of a bleed stream, which negatively affects the overall process economy. To combat this limitation, death-resistant Chinese hamster ovary cell lines were developed by simultaneously knocking out the apoptosis effector protein… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(17 citation statements)
references
References 52 publications
0
17
0
Order By: Relevance
“…Key process parameters such as cell diameter, lactate and ammonia concentrations and osmolarity, followed the trends previously observed. (MacDonald, Nöbel, Martínez, et al, 2022). At the time of growth arrest, ammonia concentrations were 2.39 mM and 3.24 mM for replicate A and B, respectively and lactate concentrations were <2 mM for both cultures (Supporting Information Material S1: Figure 1).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Key process parameters such as cell diameter, lactate and ammonia concentrations and osmolarity, followed the trends previously observed. (MacDonald, Nöbel, Martínez, et al, 2022). At the time of growth arrest, ammonia concentrations were 2.39 mM and 3.24 mM for replicate A and B, respectively and lactate concentrations were <2 mM for both cultures (Supporting Information Material S1: Figure 1).…”
Section: Resultsmentioning
confidence: 99%
“…The same parental cell line described previously served as a control (MacDonald, Nöbel, Martínez, et al, 2022). The control did not show any growth arrest and was controlled by a bleed set to maintain a constant VCD between Days 11 and 17.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been reported that for the production of unstable therapeutic proteins, such as recombinant enzymes and blood coagulation factors, the perfusion process possesses more advantages (Bettinardi et al, 2020;MacDonald et al, 2021). In the perfusion mode, culture broth contained products and waste is perfused through the bioreactor under the perfusion controller, while the cells/products are retained or recycled back into the bioreactor (Ahn et al, 2008;MacDonald et al, 2021;MacDonald et al, 2022). Consequently, a consistent and steady culture condition with metabolized by-product rapidly removal results in a stable and uniform product of high quality under perfusion culture process (Schwarz et al, 2020;Yin et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…This strategy was shown to work for fed-batch processes 191,192 and would thus be an interesting follow-up study to progress with the intensification strategy proposed in this thesis. Also, for continuous perfusion process, apoptosis resistance via Bax and Bak knock-out adds value, as demonstrated by MacDonald et al 193 . Not only was the cell longevity extended, while maintaining productivity and quality, but also the needed cell bleed rate of the perfusion process was lower as cell growth was reduced and thus product losses can be avoided.…”
Section: An Ideal Cell Line For Intensified Processes Shouldmentioning
confidence: 91%